<VariationArchive RecordType="classified" VariationID="545470" VariationName="NM_001105558.1(WEE2):c.1477dup (p.Thr493fs)" VariationType="Duplication" Accession="VCV000545470" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-04" DateCreated="2018-06-12" MostRecentSubmission="2023-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="535730" VariationID="545470">
      <GeneList>
        <Gene Symbol="WEE2" FullName="WEE2 oocyte meiosis inhibiting kinase" GeneID="494551" HGNC_ID="HGNC:19684" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="141708353" stop="141731271" display_start="141708353" display_stop="141731271" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NW_003315922.2" start="80953" stop="103871" display_start="80953" display_stop="103871" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="141408152" stop="141431070" display_start="141408152" display_stop="141431070" Strand="+" />
          </Location>
          <OMIM>614084</OMIM>
        </Gene>
        <Gene Symbol="WEE2-AS1" FullName="WEE2 antisense RNA 1" GeneID="285962" HGNC_ID="HGNC:48669" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="141704338" stop="141738230" display_start="141704338" display_stop="141738230" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NW_003315922.2" start="76938" stop="110830" display_start="76938" display_stop="110830" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001105558.1(WEE2):c.1477dup (p.Thr493fs)</Name>
      <CanonicalSPDI>NC_000007.14:141727383:AAAAA:AAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="141727383" stop="141727384" display_start="141727383" display_stop="141727384" variantLength="1" positionVCF="141727383" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="141427183" stop="141427184" display_start="141427183" display_stop="141427184" variantLength="1" positionVCF="141427183" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>T493fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.141427188dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.141427188dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.141727388dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.141727388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001105558.1" sequenceAccession="NM_001105558" sequenceVersion="1" change="c.1477dup" MANESelect="true">
            <Expression>NM_001105558.1:c.1477dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001099028.1" sequenceAccession="NP_001099028" sequenceVersion="1" change="p.Thr493fs">
            <Expression>NP_001099028.1:p.Thr493fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001105558.1" sequenceAccession="NM_001105558" sequenceVersion="1" change="c.1473dupA" MANESelect="true">
            <Expression>NM_001105558.1:c.1473dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="614084.0002" DB="OMIM" />
        <XRef Type="rs" ID="1554416415" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001105558.1(WEE2):c.1477dup (p.Thr493fs) AND Oocyte maturation defect 5" Accession="RCV000656453" Version="4">
        <ClassifiedConditionList TraitSetID="43589">
          <ClassifiedCondition DB="MedGen" ID="C4693865">Oocyte maturation defect 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-04-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-06-12" MostRecentSubmission="2023-04-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29606300</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="43589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40080" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5</ElementValue>
                <XRef Type="MIM" ID="617996" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614084.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614084.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614084.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614084.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614084.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oocyte maturation defect 5</ElementValue>
                <XRef ID="MONDO:0020837" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OOMD5</ElementValue>
                <XRef Type="MIM" ID="617996" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OZEMA5</ElementValue>
                <XRef Type="MIM" ID="617996" DB="OMIM" />
              </Symbol>
              <XRef ID="C4693865" DB="MedGen" />
              <XRef ID="MONDO:0020837" DB="MONDO" />
              <XRef Type="MIM" ID="617996" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1517973" SubmissionDate="2019-10-18" DateLastUpdated="2023-04-15" DateCreated="2018-06-12">
        <ClinVarSubmissionID localKey="614084.0002_OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5" title="WEE2, 1-BP DUP, 1473A_OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5" />
        <ClinVarAccession Accession="SCV000778441" DateUpdated="2023-04-15" DateCreated="2018-06-12" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 34-year-old Chinese woman (family 2) with infertility due to an oocyte maturation defect (OZEMA5; 617996), Sang et al. (2018) identified homozygosity for a 1-bp duplication (c.1473dupA, NM_001105558.1) in exon 10 of the WEE2 gene, causing a frameshift predicted to result in a premature termination codon (Thr493AsnfsTer39). Her unaffected parents were both heterozygous for the mutation, which was not found in the East Asian population of the 1000 Genomes Project database or in the ExAC database. Immunofluorescence analysis of transfected HeLa cells indicated that nuclear localization of the Thr493AsnfsTer39 mutant was not affected, but the protein level was slightly reduced; these results were confirmed in transfected mouse germinal-vesicle oocytes. Western blot of transfected HeLa cells showed that levels of the Thr493AsnfsTer39 mutant were significantly lower than those of wildtype WEE2. Serine phosphorylation of WEE2 was significantly increased with the mutant compared to wildtype, but phosphorylation of CDC2 (CDK1; 116940), required for pronuclei formation, was reduced. Injection of the Thr493AsnfsTer39 mutant into mouse oocytes in metaphase II significantly reduced the rate of pronuclei formation.</Attribute>
              <Citation>
                <ID Source="PubMed">29606300</ID>
              </Citation>
              <XRef DB="OMIM" ID="617996" Type="MIM" />
              <XRef DB="OMIM" ID="116940" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WEE2" />
          </GeneList>
          <Name>WEE2, 1-BP DUP, 1473A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1473A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614084.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1517973" TraitType="Disease" MappingType="Name" MappingValue="OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5" MappingRef="Preferred">
        <MedGen CUI="C4693865" Name="Oocyte maturation defect 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

